02481nam 2200541Ia 450 991078962260332120230725030939.01-60805-092-0(CKB)2670000000078962(EBL)864228(OCoLC)779141412(SSID)ssj0000674334(PQKBManifestationID)11449379(PQKBTitleCode)TC0000674334(PQKBWorkID)10662540(PQKB)10449990(MiAaPQ)EBC864228(Au-PeEL)EBL864228(CaPaEBR)ebr10457989(EXLCZ)99267000000007896220031010d2011 uy 0engur|n|---|||||txtccrMolecular aspects of neurodegeneration and neuroprotection /edited by Akhlaq A. Farooqui & Tahira Farooqui[S.l.] Bentham Science Publishers[2011]1 online resource (vi, 146 pages) illustrationsDescription based upon print version of record.1-60805-376-8 Includes bibliographical references and index.01 Title Page.pdf; 02 Cover Page; 04 CONTENTS; 05 Foreword; 06 PREFACE; 07 CONTRIBUTORS; 09 chapter 1; 10 chapter 2; 11 chapter 3; 12 chapter 4; 13 chapter 5; 14 chapter 6; 15 chapter 7; 16 chapter 8; 17 chapter 9; 18 chapter 10; 19 chapter 11; 20 indexNeurodegenerative diseases are a complex heterogeneous group of diseases associated with site-specific premature and slow death of certain neuronal populations in brain and spinal cord tissues. For example, in Alzheimer disease, neuronal degeneration occurs in the nucleus basalis, whereas in Parkinson disease, neurons in the substantia nigra die. The most severely affected neurons in Huntington disease are striatal medium spiny neurons. The neuronal populations that are lost in neurodegenerative diseases modulate functions such as controlling movements, processing sensory information, memory,BrainDegenerationNeuroprotective agentsBrainDegeneration.Neuroprotective agents.600Farooqui Akhlaq A.Farooqui TahiraMiAaPQMiAaPQMiAaPQBOOK9910789622603321Molecular aspects of neurodegeneration and neuroprotection3808862UNINA